Smartinhaler maker Adherium heads to the US market with D2C push

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

from MobiHealthNews http://ift.tt/2E5eecs